Ghisallo Capital Management LLC Cor Medix Inc. Transaction History
Ghisallo Capital Management LLC
- $1.98 Billion
- Q2 2025
A detailed history of Ghisallo Capital Management LLC transactions in Cor Medix Inc. stock. As of the latest transaction made, Ghisallo Capital Management LLC holds 750,000 shares of CRMD stock, worth $8.5 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
750,000Holding current value
$8.5 Million% of portfolio
0.47%Shares
2 transactions
Others Institutions Holding CRMD
# of Institutions
188Shares Held
33.2MCall Options Held
867KPut Options Held
561K-
Vanguard Group Inc Valley Forge, PA4.33MShares$49 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$40.3 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.58MShares$29.2 Million0.04% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.71MShares$19.4 Million0.0% of portfolio
-
State Street Corp Boston, MA1.6MShares$18.1 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $467M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...